3.08
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
Artelo Biosciences | S-3: Registration statement for specified transactions by certain issuers - Moomoo
Artelo Biosciences may offer securities up to $75 millionSEC filing - marketscreener.com
Artelo Biosciences (NASDAQ: ARTL) files $75M shelf, includes $69.29M unsold - Stock Titan
What's behind the rise in Artelo Biosciences stock? - MSN
Why did ARTL stock skyrocket over 141% pre-market today? - MSN
Avis Budget Group, Toyota Motor and other big stocks moving lower in Monday's pre-market session - MSN
Artelo Biosciences (ARTL) Partners with ScienceMachine for AI-Dr - GuruFocus
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - The Manila Times
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence Leader Sciencemachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - marketscreener.com
Why is ARTL stock soaring pre-market today? - MSN
ARTL Stock Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
Artelo Biosciences stock soars after withdrawing SEC filing - MSN
Artelo (ARTL) Stock Fundamentals | Q4 2025: EPS Exceeds ExpectationsRetail Trader Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
ARTL (Artelo Biosciences Inc.) delivers 97.5 percent positive Q4 2025 EPS surprise, but shares drop 8.64 percent today. - Cổng thông tin điện tử tỉnh Tây Ninh
What's Behind The Rise In Artelo Biosciences Stock? - Sahm
Artelo Biosciences (ARTL) Publishes Insightful Research on Pain Management - GuruFocus
Artelo (ARTL) Stock Short Interest Analysis (Smart Money Flows) 2026-04-20Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
ARTL Stock In Play As Pipeline Expands And Nasdaq Risk Eases - StocksToTrade
ARTL Stock Draws Traders As Biotech Pipeline Expands - timothysykes.com
Artelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel - Quiver Quantitative
ARTL Stock Whipsaws As Artelo Biosciences Expands High-Risk, High-Reward Pipeline - timothysykes.com
Top movers in Monday's pre-market session - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Artelo Biosciences Highlights Promising Efficacy and Safety Profile of ART26.12 as a Novel Pain Treatment Ahead of Upcoming Clinical Studies - Quiver Quantitative
Artelo says non-opioid pain drug had no serious drug-related events - Stock Titan
Artelo Biosciences Inc (ARTLW) - Minichart
Artelo Biosciences (NASDAQ: ARTL) registers 9.82M shares for resale, warrants included - Stock Titan
[EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing - Stock Titan
Artelo Biosciences Stock Short Interest Rises to 64.32% - Quiver Quantitative
ARTL Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Aug Wrap: What is the cash position of Artelo Biosciences Inc2026 Setups & Daily Market Momentum Tracking - baoquankhu1.vn
Panic Selling: What is the cash position of Artelo Biosciences IncQuarterly Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Artelo Biosciences regains Nasdaq listing compliance By Investing.com - Investing.com Australia
Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble - marketscreener.com
9.8M Artelo Biosciences (ARTL) shares registered for resale after March 2026 PIPE - Stock Titan
Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements - Moomoo
Artelo Biosciences regains Nasdaq listing compliance - Investing.com
Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments - Minichart
Why Is ARTL Stock Soaring Pre-Market Today? - Stocktwits
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Artelo Biosciences regains Nasdaq compliance, subject to one-year panel monitor - TradingView — Track All Markets
Artelo Biosciences (NASDAQ: ARTL) regains full Nasdaq listing compliance - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):